InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: DD222 post# 287184

Monday, 07/20/2020 7:14:59 PM

Monday, July 20, 2020 7:14:59 PM

Post# of 426264
Abivertinib, shuts off two cellular signals that can cause inflammation. Unchecked inflammation, known as cytokine storms,

Hard to predict where this is going..Researchers stating they are targeting patients in the ICUs who are not on a ventilator...Cytokine Storm is the immune inflammatory systems out of control. Not on a ventilator... So not sure who they are treating here..Small scale study 40 patients....probably would work if every patient in the study was in dire straights..But this seems to be another Gilead study where we don't really have a meaty end point...This looks like plan to get some free publicity...

Hoping to hit the jackpot..My money would be on Vascepa..

":>) JL

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News